We are live on ! Find out more
BRWA

B. Riley Wealth Advisors Portfolio holdings

AUM $1.87B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+37.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.18B
AUM Growth
+$160M
Cap. Flow
+$92.6M
Cap. Flow %
7.88%
Top 10 Hldgs %
17.13%
Holding
926
New
118
Increased
449
Reduced
243
Closed
89

Sector Composition

Rank Sector Weight
1 Technology 10.71%
2 Financials 7.26%
3 Healthcare 7.01%
4 Communication Services 5.7%
5 Consumer Discretionary 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STEL
601
DELISTED
Stellar Bancorp
STEL
$303K 0.03%
+9,732
New +$286K
VTA
602
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$299K 0.03%
26,270
+171
+0.7% +$1.89K
DBO icon
603
Invesco DB Oil Fund
DBO
$401M
$297K 0.03%
27,800
ZS icon
604
Zscaler
ZS
$24.9B
$297K 0.03%
6,383
-395
-6% -$18.3K
BKI
605
DELISTED
Black Knight, Inc. Common Stock
BKI
$296K 0.03%
+4,570
New +$283K
PPLI
606
People Inc
PPLI
$3.12B
$295K 0.03%
+6,608
New +$266K
DPZ icon
607
Domino's
DPZ
$11.9B
$294K 0.03%
1,000
-311
-24% -$85.7K
XTN icon
608
State Street SPDR S&P Transportation ETF
XTN
$390M
$292K 0.02%
4,536
+1,080
+31% +$68.3K
ILCV icon
609
iShares Morningstar Value ETF
ILCV
$1.31B
$291K 0.02%
4,952
+8
+0.2% +$454
DHR icon
610
Danaher
DHR
$138B
$289K 0.02%
2,120
-1,615
-43% -$204K
BFAM icon
611
Bright Horizons
BFAM
$4.35B
$288K 0.02%
1,911
-21
-1% -$3.15K
DSU icon
612
BlackRock Debt Strategies Fund
DSU
$592M
$288K 0.02%
25,701
-5,277
-17% -$57.3K
KPTI icon
613
Karyopharm Therapeutics
KPTI
$155M
$288K 0.02%
+1,000
New +$217K
ORI icon
614
Old Republic International
ORI
$10.9B
$288K 0.02%
12,850
CRSP icon
615
CRISPR Therapeutics
CRSP
$4.69B
$287K 0.02%
+4,704
New +$257K
RITM icon
616
Rithm Capital
RITM
$5.58B
$286K 0.02%
17,713
+219
+1% +$3.44K
K
617
DELISTED
Kellanova
K
$284K 0.02%
+4,368
New +$265K
SILV
618
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$284K 0.02%
+42,000
New +$248K
JRO
619
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$284K 0.02%
28,419
-47
-0.2% -$449
BILI icon
620
Bilibili
BILI
$7.75B
$283K 0.02%
+15,181
New +$246K
CIM
621
Chimera Investment
CIM
$1.06B
$283K 0.02%
4,584
+250
+6% +$15.3K
BIO icon
622
Bio-Rad Laboratories Class A
BIO
$8.76B
$282K 0.02%
+758
New +$267K
CTVA icon
623
Corteva
CTVA
$60.5B
$281K 0.02%
9,508
-1,407
-13% -$37.3K
SCHG icon
624
Schwab US Large-Cap Growth ETF
SCHG
$58.2B
$281K 0.02%
24,088
-3,584
-13% -$39.5K
MMP
625
DELISTED
Magellan Midstream Partners, L.P.
MMP
$280K 0.02%
4,448
-1,184
-21% -$73.8K

Similar funds

B. Riley Wealth Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, B. Riley Wealth Advisors held 926 positions worth $1.18B, up 16% from $1.02B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

B. Riley Wealth Advisors deployed $92.6M of net new capital in Q4 2019, opening 118 new positions and adding to 449 existing holdings. Its largest new stake was Marvell Technology: 39,411 shares worth $1.05M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Min Vol Factor ETF, an estimated $2.6M trimmed.

  • B. Riley Wealth Advisors's largest Q4 2019 buy was Marvell Technology: 39,411 shares worth $1.05M.
  • B. Riley Wealth Advisors added most to iShares US Treasury Bond ETF in Q4 2019, an estimated $5.3M increase.
  • B. Riley Wealth Advisors's biggest Q4 2019 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $2.6M.
  • B. Riley Wealth Advisors fully exited iShares S&P Small-Cap 600 Value ETF in Q4 2019, selling an estimated $1.92M.
  • B. Riley Wealth Advisors's ten largest holdings make up 17% of its $1.18B portfolio in Q4 2019.
  • B. Riley Wealth Advisors opened 118 new positions and closed 89 in Q4 2019.
  • B. Riley Wealth Advisors's portfolio value rose 16% quarter-over-quarter to $1.18B.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.